期刊文献+

MAR介导的非病毒附着体载体的研究进展 被引量:1

Research Progress of the Matrix Attachment Mediated Nonvirus Episomal Vector
下载PDF
导出
摘要 附着体载体可以使外源基因在宿主细胞中不整合到基因组上而是以附着体的形式存在,是一种新型的高效、安全、附着体表达载体。目前研究较多的是由S/MAR(Scaffold/Matrix Attachment Region,S/MAR)元件介导的质粒。虽然此类载体均能介导载体附着存在,但是转基因的表达量不同。最近研究发现,载体的启动子、骨架结构、CpG基序以及表达系统等方面能够影响转基因的表达,针对以上内容作一综述,希望据此进一步优化载体,为临床研究提供基础依据。 The new type of episomal expression vectors can make transgene expression efficient, continuous, and safety, which do not integrate into the genomes and exist in form of episome in host cells. Currently, more researches focus on episomal vectors which are mediated by scaffold/matrix attachment region components. Though episomal vectors exist in form of episome, there are many differents in the terms of transgene expression. It was found that many factors were affected on transgene expression based on the recent researches, for example, the promoter, the skeleton structure, CpG sequence of the vector, and the express system. Here the development of MAR madiated transgene expression was reviewed. According to it, it is better to optimize the vector furtherly and provide the basis for clinical researches.
出处 《生物技术通报》 CAS CSCD 北大核心 2012年第8期46-50,共5页 Biotechnology Bulletin
基金 国家自然科学基金项目(30970055)
关键词 核基质附着区 转基因表达 附着体载体 启动子 骨架结构 CPG基序 Matrix attachment region Transgene expression Episomal vector Promoter Skeleton structure CpG sequence
  • 相关文献

参考文献34

  • 1Cole A. Child in gene therapy programme develops leukaemia. BMJ, 2008, 336 : 13.
  • 2Haeein-Bey-Abina S, yon Kalle C, Sehmidt M, et al. A seriousadverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med, 2003, 348 : 255-256.
  • 3Haeein-Bey-Abina S, Von Kalle C, Schmidt M, et al. LMO2-associ- ated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science, 2003, 302 ( 5644 ) : 415-419.
  • 4Stehle IM, Postberg J, Rupprecht S, et al. Establishment and mitotic stability of an extra-chromosomal mammalian replicon. BMC Cell Biol, 2007, 8 : 33.
  • 5Wong SP, Argyros O, Coutelle C, et al. Strategies for the episomal modification of ceils. Current Opinion in Molecular Therapeutics, 2009, 11 : 433-441.
  • 6Ehrhardt A, Haase R, Schepers A, et al. Episomal vectors for gene therapy. Current Gene Ther, 2008, 8 : 147-161.
  • 7Balker A, Maercker C, Piechaczek C, et al. Mitotic stability of an episomal vector containing a human scaffold/matrix-attached gion is provided by association with nuclear matrix. Nature Cell Biol, 2000, 2 : 182-184.
  • 8Bode J, Winkelmann S, Gotze S, et al. Correlations between scaffold/ matrix attachment region ( S/MAR ) binding activity and DNA duplex destabilization energy. J Mol Biol, 2006, 358 : 597-613.
  • 9Piechaczek C, Fetzer C, Balker A, et al. A "ector based on the SV40 origin of replication and chromosomal S/MARs replicates episomally in CHO cells. Nucleic Acids Res, 1999, 27 : 426-428.
  • 10Harraghy N, Gaussin A, Mermod N. Sustained transgene expression using MAR elements. Curt Gene Ther, 2008, 8 : 353-366.

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部